Related Experiment Video
Updated: Jan 28, 2026

Genome-wide Analysis using ChIP to Identify Isoform-specific Gene Targets
Published on: July 7, 2010
Isoform-specific Ras signaling is growth factor dependent
Fiona E Hood1, Bertram Klinger2,3,4, Anna U Newlaczyl1
1Division of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, United Kingdom.
Abstract:
HRAS, NRAS, and KRAS isoforms are almost identical proteins that are ubiquitously expressed and activate a common set of effectors. In vivo studies have revealed that they are not biologically redundant; however, the isoform specificity of Ras signaling remains poorly understood. Using a novel panel of isogenic SW48 cell lines endogenously expressing wild-type or G12V-mutated activated Ras isoforms, we have performed a detailed characterization of endogenous isoform-specific mutant Ras signaling. We find that despite displaying significant Ras activation, the downstream outputs of oncogenic Ras mutants are minimal in the absence of growth factor inputs. The lack of mutant KRAS-induced effector activation observed in SW48 cells appears to be representative of a broad panel of colon cancer cell lines harboring mutant KRAS. For MAP kinase pathway activation in KRAS-mutant cells, the requirement for coincident growth factor stimulation occurs at an early point in the Raf activation cycle. Finally, we find that Ras isoform-specific signaling was highly context dependent and did not conform to the dogma derived from ectopic expression studies.
Insights
Ras signaling is not redundant across its isoforms (HRAS, NRAS, KRAS). Oncogenic Ras mutants require growth factor signals for downstream effects, challenging prior assumptions about Ras pathway activation in cancer.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- Ras isoforms (HRAS, NRAS, KRAS) are highly similar proteins activating common effectors.
- Despite structural similarities, in vivo studies indicate Ras isoforms are not biologically redundant.
- The isoform-specific mechanisms of Ras signaling remain poorly understood.
Purpose of the Study:
- To characterize endogenous isoform-specific mutant Ras signaling.
- To investigate the role of growth factor inputs in oncogenic Ras signaling.
- To determine the context dependency of Ras isoform signaling.
Main Methods:
- Utilized a novel panel of isogenic SW48 cell lines.
- Endogenously expressed wild-type or G12V-mutated activated Ras isoforms.
- Performed detailed characterization of endogenous isoform-specific mutant Ras signaling.
Main Results:
- Oncogenic Ras mutants showed minimal downstream signaling without growth factor stimulation.
- Lack of KRAS-induced effector activation in SW48 cells was observed in other colon cancer cell lines.
- MAP kinase pathway activation in KRAS-mutant cells requires early growth factor stimulation of the Raf cycle.
- Ras isoform-specific signaling is context-dependent, differing from ectopic expression studies.
Conclusions:
- Ras isoform specificity is crucial and context-dependent.
- Oncogenic Ras signaling requires coordinated growth factor input.
- Findings challenge established models of Ras signaling derived from ectopic expression studies.
Related Concept Videos
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ras Gene
Ras is a...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH

